CLINICAL ROLE -
Advancing Treatment Selection in CLL Management
Treatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.
Read More
Treatment Opportunities Continue to Advance in CLL Management
In crafting a patient-centered regimen, the convergence of expertise from physicians and pharmacists, paired with the values and preferences of patients, becomes paramount.
Real-World Efficacy, Safety of Tixagevimab/Cilgavimab in Patients With Cancer After EUA Revision
The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.